BIBLIOGRAPHY
This new section of the site is dedicated to articles related to terazosin, and provides detailed and analytical information for professional use.
These scientific documents are specifically related to terazosin and its use, and cover areas such as medical studies, the latest clinical research and new advances taking place in the pharmaceutical industry.
If you cannot find a specific article in the chronological archives below, you can use the SEARCH box situated on the left hand column.
Gateways to clinical trials.
Methods Find Exp Clin Pharmacol 2007 Nov;29(9):625-55
Switching patients with lamivudine resistant chronic hepatitis B virus from tenofovir to adefovir results in less potent HBV-DNA suppression.
J Viral Hepat 2008 Feb;15(2):108-14
Tenofovir-based rescue therapy for advanced liver disease in 6 patients coinfected with HIV and hepatitis B virus and receiving lamivudine.
Clin Infect Dis 2008 Feb;46(3):e28-30
Tenofovir DF Plus Lamivudine or Emtricitabine for Nonoccupational Postexposure Prophylaxis (NPEP) in a Boston Community Health Center.
J Acquir Immune Defic Syndr 2007 Dec;(): [Epub ahead of print]
Characterization of HIV-1 subtypes and viral antiretroviral drug resistance in men who have sex with men in Beijing, China.
AIDS 2007 Dec;21 Suppl 8():S59-65